Sam Altman says Musk aims to ‘slow down a competitor’ with his $97.4-billion bid for OpenAI

Sam Altman says Musk aims to ‘slow down a competitor’ with his .4-billion bid for OpenAI


Sam Altman on how seriously he's taking Elon Musk's bid for OpenAI: 'Not particularly'

PARIS — Elon Musk aims to “slow down a competitor” when the investor group he led put forward a $97.4 billion proposal for control of OpenAI, the company’s CEO Sam Altman told CNBC on Tuesday.

Asked how seriously he is taking Musk’s bid, which Altman previously declined in a X social media post, the OpenAI chief said: “Not particularly.”

“I think it’s to slow down a competitor and catch up with his thing, but I don’t really know … to the degree anybody does,” Altman added, in response to another reporter’s questions on the sidelines of the AI Action Summit in Paris.

CNBC has reached out to Toberoff, Tesla and X for comment.

Elon Musk is leading a group of investors in offering to buy control of OpenAI for $97.4 billion, CNBC confirmed on Monday. The offer is for the nonprofit that oversees the artificial intelligence startup behind ChatGPT.

“It’s time for OpenAI to return to the open-source, safety-focused force for good it once was,” Musk’s attorney Marc Toberoff said, adding that he submitted an offer on Monday.

Musk has his own AI company called xAI which is behind the chatbot Grok.

– CNBC’s Ari Levy and Lora Kolodny contributed to this report.

This is a breaking news story. Please check back for more.



Source

U.S.-Iran talks set to begin in Pakistani capital after delegations arrive
World

U.S.-Iran talks set to begin in Pakistani capital after delegations arrive

TOPSHOT – A policeman stands guard in front of a digital screen displaying news of USIran peace talks along a road in Islamabad on April 10, 2026. (Photo by Farooq NAEEM / AFP via Getty Images) Farooq Naeem | Afp | Getty Images Pakistan confirmed the arrival of a delegation of Iranian negotiators ahead of […]

Read More
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
World

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing […]

Read More
Consumer sentiment hits record low, inflation fears rise amid Iran war
World

Consumer sentiment hits record low, inflation fears rise amid Iran war

Consumer confidence plunged to a record low in April as fears mounted over rising energy prices and the broader impact of the Iran war, according to a University of Michigan survey Friday. The university’s headline index of consumer sentiment tumbled to 47.6, down 10.7% from the March survey to its lowest on record. Current conditions […]

Read More